Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureGregory M. Hemenway, Daniel M. Geynisman
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Perioperative apalutamide in high-risk localized prostate cancer
10.1056/nejmoa2603878 · 2026
NCCN Guidelines® insights: prostate cancer, version 5.2026
10.6004/jnccn.2026.0023 · 2026
Neoadjuvant and adjuvant therapies for high-risk prostate cancer
10.1016/j.ucl.2026.02.006 · 2026
Cancer and Leukemia Group B 90203 (alliance): radical prostatectomy with or without neoadjuvant chemohormonal therapy in localized, high-risk prostate cancer
10.1200/jco.20.00315 · 2020
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol
10.1016/s0140-6736(21)02437-5 · 2022
No additional external references are available.